Mb. Mcdonald et al., Photorefractive keratectomy for low-to-moderate myopia and astigmatism with a small-beam, tracker-directed excimer laser, OPHTHALMOL, 106(8), 1999, pp. 1481-1488
Objective: To assess the safety and effectiveness of the Autonomous Technol
ogies Corporation LADARVIsion excimer laser system for photorefractive kera
tectomy correction of myopia and astigmatism.
Design: A multicenter, prospective, noncomparative case series.
Participants: The cohort consisted of 467 eyes corrected for spherical myop
ia and 211 eyes corrected for myopia with astigmatism.
Intervention: Treatments were performed at six sites in the United States u
sing a 6-mm ablation zone for spherical myopes and a 5.5-mm zone with a 1.0
-mm blend for astigmats.
Main Outcome Measures: Visual acuity, subjective refraction, corneal haze,
intraocular pressure, complications, adverse reactions, patient satisfactio
n, and corneal endothelial changes.
Results: Twelve-month follow-up was available on 414 spherical eyes and 175
astigmatic eyes. The results for spherical eyes with correction between -1
and -5.99 diopters (D) were: uncorrected visual acuity (UCVA) of 20/40 or
better achieved by 98.1%, 20/20 or better by 72%, 1.8% lost 2 lines and 0.3
% lost greater than 2 lines of best spectacle-corrected Visual acuity (BSGV
A); 76.4% were within 0.50 D of the target correction and 94.4% were within
1.00 D. The results for myopia with astigmatism with spherical equivalent
correction between -1 and -5.99 D were: UCVA of 20/40 or better in 97.4%, 2
0/20 or better in 61.7%, 2.5% lost 2 lines and no eyes lost greater than 2
lines BSCVA; 73.9% were within 0.50 D of the target correction and 95% were
within 1.00 D. For spherical myopes combined with myopic astigmats correct
ed for 6 to 10 D, results were: UCVA of 20/40 or better in 93.4%, 20/20 or
better in 61.2%, 2.3% lost 2 lines and no eyes lost greater than 2 lines of
BSCVA; 67.2% were within 0.50 D of the desired correction and 87.8% were w
ithin 1.00 D. Refractive stability was achieved between 3 and 6 months for
the spherical and astigmatic groups. No eyes had corneal haze graded as mod
erate or greater, and there was no significant decrease in endothelial cell
density.
Conclusions: Patients treated for 1 to 10 D of spherical equivalent myopia,
with or without astigmatism, showed early refractive stability, excellent
UCVA, no significant loss of BSCVA, no loss of endothelial cell density, an
d very low levels of corneal haze to 12 months after surgery.